Key result
Type 1 diabetes in a mouse model decreased lung nitric oxide bioavailability, causing oxidative damage, enhanced platelet activation, endothelial injury, and altered vasoreactivity.
Why the study?
Diabetes pulmonary and microvascular consequences are well recognized but have not been characterized.
In a type 1 diabetic mouse model, decreased lung nitric oxide bioavailability leads to pulmonary microvascular dysfunction, suggesting a potential target for preventing systemic consequences of diabetes.
Diabetes pulmonary and microvascular consequences are well recognized but have not been characterized. We assessed lung microvascular changes in a live anesthetized mouse model of type 1 diabetes, using a novel intravital microscopy technique. Our results show new evidence that a diabetes-induced decrease in lung nitric oxide bioavailability underlies oxidative damage, enhanced platelet activation, and endothelial injury causing pulmonary microvascular dysfunction and altered vasoreactivity. These findings could provide novel strategies to prevent or reverse diabetes systemic consequences.
No takes yet. Share an insight, caveat, or question.
Moulana et al. (2021) studied Type 1 diabetes. Type 1 diabetes was evaluated on Lung microvascular changes including oxidative damage, platelet activation, and endothelial injury. Type 1 diabetes in a mouse model decreased lung nitric oxide bioavailability, causing oxidative damage, enhanced platelet activation, endothelial injury, and altered vasoreactivity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: